HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul M Loadman Selected Research

Membrane-Associated Matrix Metalloproteinases

2/2014Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy.
9/2010Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul M Loadman Research Topics

Disease

41Neoplasms (Cancer)
01/2022 - 06/2003
11Colorectal Neoplasms (Colorectal Cancer)
06/2021 - 08/2010
7Neoplasm Metastasis (Metastasis)
07/2020 - 04/2005
4Hypoxia (Hypoxemia)
01/2016 - 01/2007
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2013 - 05/2004
3Glioblastoma (Glioblastoma Multiforme)
01/2019 - 02/2008
3Adenoma (Adenomas)
12/2018 - 08/2010
3Polyps
12/2018 - 07/2013
3Adenocarcinoma
07/2015 - 06/2003
3Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2014 - 08/2010
3Colonic Neoplasms (Colon Cancer)
06/2013 - 06/2003
3Transitional Cell Carcinoma
01/2013 - 04/2005
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 01/2021
2Inflammation (Inflammations)
11/2014 - 01/2014
2Breast Neoplasms (Breast Cancer)
02/2014 - 05/2009
2Necrosis
02/2014 - 09/2010
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2021
1Non-Muscle Invasive Bladder Neoplasms
01/2019
1Hemorrhage
12/2018
1Glioma (Gliomas)
01/2017
1Hypertension (High Blood Pressure)
02/2016
1Virus Diseases (Viral Diseases)
02/2016
1Colitis-Associated Neoplasms
11/2014
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2013
1Neuroblastoma
01/2013
1Carcinoma (Carcinomatosis)
12/2012

Drug/Important Bio-Agent (IBA)

14Pharmaceutical PreparationsIBA
12/2021 - 06/2003
10ProdrugsIBA
01/2019 - 02/2004
8Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
06/2021 - 08/2010
8Eicosapentaenoic AcidIBA
06/2021 - 08/2010
7Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2003
6Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2022 - 06/2003
6DuocarmycinsIBA
01/2022 - 01/2013
6polysialic acidIBA
05/2021 - 01/2013
5EnzymesIBA
01/2021 - 06/2013
3Matrix Metalloproteinases (MMPs)IBA
01/2017 - 11/2004
3Nonesterified Fatty Acids (NEFA)IBA
11/2014 - 08/2010
3Cytotoxins (Cytolysins)IBA
06/2013 - 12/2009
3TubulinIBA
12/2012 - 02/2004
3ParaffinIBA
05/2009 - 05/2004
2ColchicineFDA LinkGeneric
01/2022 - 12/2012
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
06/2021 - 01/2021
2Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 01/2020
2apaziquone (E 09)IBA
01/2019 - 10/2006
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2018 - 07/2013
2PolymersIBA
10/2016 - 01/2016
2CarbohydratesIBA
10/2016 - 01/2016
2Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
01/2016 - 01/2013
2Peptides (Polypeptides)IBA
04/2014 - 05/2009
2ICT2588IBA
04/2014 - 09/2010
2Membrane-Associated Matrix MetalloproteinasesIBA
02/2014 - 09/2010
2Biomarkers (Surrogate Marker)IBA
01/2014 - 07/2013
2Cytochrome P-450 CYP1A1 (CYP1A1)IBA
08/2013 - 01/2013
2AQ4NIBA
12/2009 - 02/2008
2Formaldehyde (Formol)FDA Link
05/2009 - 10/2004
1N- (1- (7- fluoro- 2- (pyridin- 2- yl)quinolin- 3- yl)ethyl)- 9H- purin- 6- amineIBA
01/2022
1N-Acetylneuraminic Acid (Sialic Acid)IBA
05/2021
1endo-alpha-sialidaseIBA
05/2021
1Polysaccharides (Glycans)IBA
05/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Protein Isoforms (Isoforms)IBA
01/2021
1hydroxide ionIBA
01/2021
1CarcinogensIBA
01/2021
1Liposomes (Liposome)IBA
01/2020
1Temozolomide (Temodar)FDA LinkGeneric
01/2017
1GlycosyltransferasesIBA
10/2016
1Peptide Hydrolases (Proteases)FDA Link
02/2016
1Protease Inhibitors (Protease Inhibitor)IBA
02/2016
1Cell Adhesion MoleculesIBA
01/2016
1Phospholipids (Phosphatides)FDA LinkGeneric
07/2015
1vadimezanIBA
07/2015
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
11/2014
1Dietary Fats (Dietary Fat)IBA
11/2014
1Indicators and Reagents (Reagents)IBA
04/2014
1von Willebrand FactorIBA
04/2014
1Ferrosoferric Oxide (Magnetite)FDA Link
02/2014
1cyclopropapyrroloindoleIBA
08/2013
1Fish OilsIBA
07/2013
1Warfarin (Coumadin)FDA LinkGeneric
07/2013
1Histones (Histone)IBA
06/2013
1(1- (chloromethyl)- 1,2- dihydropyrrolo(3,2- e)indol- 3(6H)- yl)(5- fluoro- 1H- indol- 2- yl)methanoneIBA
06/2013
1(5- chloro- 1H- indol- 2- yl)(1- (chloromethyl)- 1,2- dihydropyrrolo(3,2- e)indol- 3(6H)- yl)methanoneIBA
06/2013
1Mixed Function Oxygenases (Monooxygenases)IBA
06/2013
1(1- (chloromethyl)- 1,2- dihydropyrrolo(3,2- e)indol- 3(6H)- yl)(5- methoxy- 1H- indol- 2- yl)methanoneIBA
01/2013
1(3,4-difluorobenzyl-N-aminocolchicine)IBA
12/2012
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
09/2010

Therapy/Procedure

10Therapeutics
12/2021 - 10/2004
4Precision Medicine
01/2019 - 02/2014
3Drug Therapy (Chemotherapy)
01/2021 - 06/2013
2Radiotherapy
01/2021 - 01/2019
2Chemoprevention
12/2018 - 07/2013
2Lasers (Laser)
07/2015 - 11/2011
1Immunotherapy
01/2021
1Intravenous Injections
01/2020
1Microbubbles
01/2020
1Oral Administration
11/2014
1Intravenous Administration
02/2014
1Gastrectomy
01/2014
1Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2014